Business Context and Reporting Period
Company: OraSure Technologies, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 30, 2007
Event Date: November 30, 2007
The filing reports the renewal of a material supply and distribution agreement between OraSure Technologies, Inc. and Abbott Laboratories regarding the OraQuick ADVANCE Rapid HIV-1/2 Antibody Test.
Key Financial Metrics
This filing does not contain financial statements, revenue figures, profit margins, cash flow data, debt levels, or liquidity metrics. The document focuses exclusively on a contractual event.
Material Changes
- Agreement Renewal: The Original Supply and Distribution Agreement, initially dated February 11, 2005, was set to expire on December 31, 2007.
- Renewal Notice: On November 30, 2007, OraSure received a formal notice of renewal from Abbott Laboratories.
- Extension: The agreement has been renewed for the calendar year 2008.
- Future Terms: The renewed agreement remains subject to annual renewal provisions at the end of the 2008 term.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the continuation of the distribution relationship for the OraQuick ADVANCE test in U.S. hospitals and certain other markets.
Risks and Contingencies: The filing does not disclose new risks or contingencies. It notes that the agreement is subject to annual renewal provisions, implying the relationship is not guaranteed beyond the 2008 calendar year without further notice.
Key Facts for Investor Verification
- Verify the specific financial terms (royalties, minimum guarantees) of the renewed 2008 agreement, as they are not detailed in this 8-K.
- Confirm the status of the annual renewal provision for the end of 2008 to assess long-term revenue stability.
- Review subsequent filings for any changes in the scope of markets or products covered under the Abbott distribution agreement.